Tamoxifen versus tamoxifen plus doxorubicin and cyclophosphamide as adjuvant therapy for node-positive postmenopausal breast cancer: results of a Japan Clinical Oncology Group Study (JCOG9401)
2014 ◽
Vol 19
(6)
◽
pp. 982-988
◽
2014 ◽
Vol 74
(3)
◽
pp. 603-609
◽
2017 ◽
Vol 47
(7)
◽
pp. 664-667
◽
2012 ◽
Vol 96
(1)
◽
pp. 74-83
◽
2016 ◽
Vol 83
(5)
◽
pp. AB164
◽
2009 ◽
Vol 39
(6)
◽
pp. 406-409
◽
2005 ◽
Vol 35
(1)
◽
pp. 34-36
◽